Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2009
06/03/2009EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
06/03/2009EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
06/03/2009EP2065396A1 Interleukin-19
06/03/2009EP2064336A2 Interleukin -13 binding proteins
06/03/2009EP2064335A2 Molecules with reduced half-lives, compositions and uses thereof
06/03/2009EP2064334A2 Aldehyde tags, uses thereof in site-specific protein modification
06/03/2009EP2064315A2 Glycolysis-inhibiting substances in cell culture
06/03/2009EP2063912A2 Polyalkylene oxides having hindered ester-based biodegradable linkers
06/03/2009EP2063850A2 Vipr1s as modifiers of the e2f/rb pathway and methods of use
06/03/2009EP1945791A4 Expression of soluble factor viii proteins in bacteria
06/03/2009EP1859043A4 Phage-derived vectors and methods for protein expression
06/03/2009EP1407017B1 Human tumor necrosis factor receptor
06/03/2009EP1399472B1 Soluble heterodimeric cytokine receptor
06/03/2009EP1362058B1 Comparative ligand mapping from mhc positive cells
06/03/2009EP1111054B1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them
06/03/2009EP1012283B1 Mage-3 peptides presented by hla class ii molecules
06/03/2009EP0985032B2 Ribosome complexes as selection particles for in vitro display and evolution of proteins
06/03/2009CN101448951A Fusion proteins, uses thereof and processes for producing same
06/03/2009CN101446590A Methods for the identification of polypeptide antigens
06/03/2009CN101445821A Method for preparing deer byproduct collagen and functional collagen protein taken as medical and function foods
06/03/2009CN101445820A Method for preparing antibacterial metabolin of Propionibacterium and use thereof
06/03/2009CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
06/03/2009CN100494397C Preparation method for extracting collagen helix polypeptide from tendon of sea cucumber
06/03/2009CN100494396C Method for preparing antihypertensive peptides by using proteins in shrimps
06/03/2009CN100494388C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
06/03/2009CN100494386C Method for yeast cell to express human interleukin 10
06/03/2009CN100494362C Carbohydrates and polyols for dissolving protein crystal
06/03/2009CN100494344C New biopesticide using gene from erwinia pyrifoliaeWT#3, novel pathogen that affects asian pear trees
06/03/2009CN100494213C Process for preparing synergistic factor in artificial blood, nucleotide sequence used thereby
06/03/2009CN100493486C Kit for pharmaceutical use
06/02/2009US7541450 producing the hybrid proteins comprising a single polypeptide having a target protein with a ligand-dependent intein embedded in the sequence of target proteins; modulation of protein activity; molecular switches
06/02/2009US7541449 DNA segment encoding the enzyme inhibitor for therapy of thrombosis, blood disorders; biodrugs; genetic vaccines; monoclonal antibodies; host cells
06/02/2009US7541446 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins
06/02/2009US7541443 A humanized antibody for use as immunosuppressants, treating or preventing transplant rejection in human patient; drug screening
06/02/2009US7541442 Antibodies and related molecules that bind to PSCA proteins
06/02/2009US7541440 Invention provides monoclonal antibody or fragment thereof that binds granulocyte (neutrophil) antigen, preferably provides humanized, chimeric and human anti-granulocyte-targeting antibodies, such as MN3 antibodies, useful for treatment and diagnosis of malignancy diseases resulting from ischemic injury
06/02/2009US7541438 Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
06/02/2009US7541436 covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides treating Hepatitis-C virus
06/02/2009US7541435 Antagonists of cxcr3-binding cxc chemokines
06/02/2009US7541434 Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants
06/02/2009US7541432 L-glutamate-gated chloride channel proteins from Rhipicephalus sanguineus
06/02/2009US7541429 Comparative ligand mapping from MHC positive cells
06/02/2009US7541336 Prepared by culturing a microorganism belonging to fungi and having ability to produce FKI-1033 substance in a medium; use in agrochemicals, veterinary medicines and pharmaceuticals having an activity of ryanodine binding inhibition, an insecticidal and anthelmintic activity
06/02/2009US7541334 Hybrid peptides modulate the immune response
06/02/2009US7541174 Bacterial host cell for the direct expression of peptides
06/02/2009US7541164 Mammalian cell culture processes for protein production
06/02/2009US7541163 Expression vector comprising nucleotide sequences coding multifunctional protein with viricidal activity
06/02/2009US7541162 Virus harboring a DNA encoding a subunit of limulus-derived factor G; capable of mass-producing a (1 --> 3)- beta -D-glucan assay reagent of satisfactory quality, steadily and at low cost; nuclear polyhedrosis virus
06/02/2009US7541139 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins
06/02/2009US7541040 Chimeric molecule for the treatment of th2-like cytokine mediated disorders
06/02/2009US7541033 Humanized anti-IL-1β antibodies
06/02/2009US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα
06/02/2009US7541029 Anti-rhesus D monoclonal antibodies
06/02/2009CA2321664C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/02/2009CA2267101C Thermostable nucleic acid polymerase from thermococcus gorgonarius
05/2009
05/28/2009WO2009066761A1 Process for production of non-natural protein having ester bond therein
05/28/2009WO2009066758A1 Translation regulation system in cell or artificial cell model by using low-molecular-weight rna
05/28/2009WO2009066757A1 Protein-responsive translation control system utilizing rna-protein interaction motif
05/28/2009WO2009066702A1 Anti-hiv monoclonal antibody
05/28/2009WO2009066655A1 Human antibody capable of inducing apoptosis
05/28/2009WO2009065862A1 Improved bioactive peptide production
05/28/2009WO2009065292A1 Fusion protein comprising tumor necrosis factor related apoptosis inducing ligand and integrin ligand and use thereof
05/28/2009WO2009049274A3 Microorganism engineered to produce isopropanol
05/28/2009WO2009023773A3 Galactokinase inhibitors
05/28/2009WO2008140478A4 Compositions and methods for immunodominant antigens
05/28/2009WO2008103472A3 Prevention and treatment of synucleinopathic and amyloidogenic disease
05/28/2009WO2007067596A3 Methods and compositions for needleless delivery of antibodies
05/28/2009WO2007009069A3 Heat lysis production of proteins
05/28/2009WO2006132966A3 Webbed hiv envelope immunogens, methods for production and use of same
05/28/2009WO2006023248A3 Processes for producing and crystallizing g-protein coupled receptors
05/28/2009US20090137782 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer
05/28/2009US20090137502 Riproximin, a Novel Type II Ribosome-Inactivating Protein and Uses Thereof
05/28/2009US20090137484 Neuronal Network-Interacting Peptide
05/28/2009US20090137481 Antimicrobial polypeptides
05/28/2009US20090137476 Apo-2 ligand variants and uses thereof
05/28/2009US20090137471 Ngf variants
05/28/2009US20090137468 Cytotoxic factors for modulating cell death
05/28/2009US20090137051 Monoclonal Antibodies Directed Against The Microtubule-Associated Protein Tau
05/28/2009US20090137036 Tweak receptor
05/28/2009US20090137035 Tweak receptor
05/28/2009US20090137033 Novel fluorescent proteins from aequorea coerulscens and methods for using same
05/28/2009US20090137005 IL-12 for Expression in Mammalian Cell
05/28/2009US20090137004 Artificial entropic bristle domain sequences and their use in recombinant protein production
05/28/2009US20090137003 Methods for recombinant manufacturing of anti-RSV antibodies
05/28/2009US20090137002 Anti ephb4 antibodies and antibody fragments
05/28/2009US20090137001 Process for preparing recombinant human thrombin with culture cell
05/28/2009US20090137000 Dna polymerases and related methods
05/28/2009US20090136999 Compositions and methods for immunotherapy of cancer and infectious diseases
05/28/2009US20090136998 Luciferases and methods for making and using the same
05/28/2009US20090136997 Pro1550 polypeptides and nucleic acids encoding the same
05/28/2009US20090136996 Novel cysteine-depleted hydrophobin fusion proteins, their production and use thereof
05/28/2009US20090136995 Mutated Prokaryotic Cells with High Secretion-Levels
05/28/2009US20090136994 Polypeptide having amidase activity and gene thereof
05/28/2009US20090136993 Process for the Production of Gamma-Glutamylcysteine
05/28/2009US20090136975 transient receptor potential (TRP) family of ion channels; recombinant vectors, host cells; high throughput screening, drug screening
05/28/2009US20090136971 Multiplex liquid tissue method for increased proteomic coverage from histopathologically processed biological samples, tissues, and cells
05/28/2009US20090136970 Nogo receptor homologues and their use
05/28/2009US20090136969 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy
05/28/2009US20090136959 Novel genes encoding proteins having prognostic, diagnostic preventive, therapeutic, and other uses
05/28/2009US20090136928 Compositions and Methods for the Diagnosis and Treatment of Tumor